[1]
L. S. Ping and A. B. Nasruddin, “PREVALENCE OF LOW BONE MINERAL DENSITY AND ITS ASSOCIATED RISK FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER RECEIVING TSH SUPPRESSION THERAPY”, J ASEAN Fed Endocr Soc, vol. 37, p. 4, Jul. 2022.